283
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Howell-Jolly Body-Like Inclusions in Coronavirus Disease 2019 (COVID-19): Possible Novel Findings

, , , ORCID Icon &
Pages 233-238 | Received 07 Dec 2022, Accepted 17 Mar 2023, Published online: 29 Mar 2023

References

  • Prokocimer M, Potasman I. The added value of peripheral blood cell morphology in the diagnosis and management of infectious diseases—part 1: basic concepts. Postgrad Med J. 2008;84(997):579–585. doi:10.1136/pgmj.2008.069609
  • Sears DA, Udden MM. Howell-Jolly bodies: a brief historical review. Am J Med Sci. 2012;343(5):407–409. doi:10.1097/MAJ.0b013e31823020d1
  • William BM, Corazza GR. Hyposplenism: a comprehensive review. Part I: basic concepts and causes. Hematology. 2007;12(1):1–13.
  • Ong SY, Ng HJ. Howell–Jolly bodies in systemic amyloidosis. Int J Hematol. 2018;108(2):119–120. doi:10.1007/s12185-018-2473-8
  • Mathew H, Dittus C, Malek A, Negroiu A. Howell-Jolly bodies on peripheral smear leading to the diagnosis of congenital hyposplenism in a patient with septic shock. Clin Case Rep. 2015;3(8):714. doi:10.1002/ccr3.323
  • Chang B, Huang RSP, Dasgupta A, Nguyen N, Wahed A. Prevalence of Howell-Jolly body-like inclusions in HIV patients and their correlation with CD4 counts and HIV RNA viral load. Ann Clin Lab Sci. 2015;45(1):23–26.
  • Alisjahbana B, Huang I, Oehadian A. The detection of Howell-Jolly body-like inclusions in a case of coronavirus disease-2019 (COVID-19). Blood Res. 2020;55(4):191. doi:10.5045/br.2020.2020186
  • Koçyiğit B, Sayin S, Şişman FO, Kizilkaya S, Ayrik MY. Coronavirus disease-19 (Covid-19): the disease that changed the world. Turkish Med Student J. 2020;7(2):96–105. doi:10.4274/tmsj.galenos.2020.07.02.07
  • Bain BJ. Blood Cells: A Practical Guide. Philadelphia: Lippincott; 1989.
  • Andre E, Chevalier C, Scheiff JM. Howell‐Jolly‐like bodies in leucocytes: first description in leucocytes other than neutrophils. Eur J Haematol. 2011;86(2):182–183. doi:10.1111/j.1600-0609.2010.01543.x
  • Pozdnyakova O, Connell NT, Battinelli EM, Connors JM, Fell G, Kim AS. Clinical significance of CBC and WBC morphology in the diagnosis and clinical course of COVID-19 infection. Am J Clin Pathol. 2021;155(3):364–375. doi:10.1093/ajcp/aqaa231
  • Güçlü E, Kocayiğit H, Okan HD, et al. Effect of COVID-19 on platelet count and its indices. Revista da Associação Médica Brasileira. 2020;66:1122–1127. doi:10.1590/1806-9282.66.8.1122
  • ElMaraghy AA, AbdelFattah EB, Ahmed MS. Platelet count: is it a possible marker for severity and outcome of community acquired pneumonia? Egypt J Chest Dis Tuberc. 2016;65(2):499–504. doi:10.1016/j.ejcdt.2015.09.001
  • Yin S, Huang M, Li D, Tang N. Difference of coagulation features between severe pneumonia induced by SARS-CoV2 and non-SARS-CoV2. J Thromb Thrombolysis. 2021;51(4):1107–1110. doi:10.1007/s11239-020-02105-8
  • Weinberg SE, Behdad A, Ji P. Atypical lymphocytes in peripheral blood of patients with COVID‐19. Br J Haematol. 2020;190:24–39. doi:10.1111/bjh.16848
  • Fouad SH, Allam MF, Taha SI, et al. Comparison of hemoglobin level and neutrophil to lymphocyte ratio as prognostic markers in patients with COVID-19. J Int Med Res. 2021 Jul;49(7):03000605211030124
  • Kamel FO, Magadmi RM, Alqutub ST, et al. Clinical and hematologic presentations of adults with COVID-19 patients in Jeddah: a case control study. J Infect Public Health. 2021;14(6):709–716. doi:10.1016/j.jiph.2021.03.007
  • Paudel SS. A meta-analysis of 2019 novel Corona virus patient clinical characteristics and comorbidities; 2020.
  • Chen T, Wu D, Chen H, Yan W, Yang D, Chen G, et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. bmj. 2020;368